Morgan Stanley: Moderna CEO Stéphane Bancel Omicron and mRNA Tech

446   2 years ago
446   2 years ago
As the world faces Omicron and other potential COVID-19 variants, many are asking, are we stuck with COVID forever?

In this special episode of Exceptional Leaders / Exceptional Ideas, Matthew Harrison, Equity Analyst covering Biotechnology, sits down with Stéphane Bancel, CEO of Moderna, to discuss what it was like during the most trying periods of vaccine development, Stéphane’s views on new variants and the possibilities ahead for mRNA technology.
Please log in or register to post comments